News Events — Levensten Law Firm P C

Latest News
•	Philadelphia Nursing Home Lawsuit Information
•	Yaz Birth Control Information
•	Influend Cough and Cold Products Information
•	MRI Injury Lawsuit Information
•	Digoxin Information
•	Rythmol Information
•	Zencore Plus Information
•	Reglan Information
•	Zonegran Information
•	Raptiva Information
•	F.D.A. Announces Voluntary Recall of Zelnorm®
•	F.D.A. Announces Voluntary Withdrawal of Pergolide Products

Past Articles
•	FDA Requests Boxed Warnings on Levaquin, Avelox and Cipro Because of Increased Risk of Tendinitis and Tendon Rupture
•	Serious Injuries and Death Have Been Associated With the Use of Heparin
•	Serious Injuries and Death Have Been Associated With the Use of Heparin Q&A
•	FDA Requests Black Boxed Warnings For Gadolinium Based Contrast Agents
•	FDA Requests Marketing Suspension of Trasylol Because of Risk of Renal Failure and Death
•	FDA Requests Marketing Suspension of Trasylol Because of Risk of Renal Failure and Death Q&A
•	Class I Nationwide Recall Of Digitek
•	Chantix Associated With Serious Neuropsychiatric Injuries Includign Attempted And Committed Suicide
•	F.D.A. Announces Voluntary Recall of Zelnorm®
•	F.D.A. Announces Voluntary Withdrawal of Pergolide Products
•	Class 1 Recall: Bard® Composix® Kugel® Mesh Patch - Expansion
•	FDA Issues Public Health Advisory for Trasylol
•	"How Safe is Celebrex®?" - Boston Globe
•	"Study Could Hurt Stent Sales" - Forbes
•	"Warning on Cox-2 Drugs" - The Street
•	"New Warning for ADHD Drugs" - The Street

News on Vioxx
•	Merck Withdraws Vioxx; F.D.A. Issues Public Health Advisory
•	"Merck's Multibillion Dollar Bet" - Boston Globe
News on Ketek
•	FDA Public Health Advisory: Ketek (telithromycin) Tablets
•	"F.D.A. Warns of Liver Failure After Antibiotic" - New York Times
•	"F.D.A. Restricts Ketek's Commercial Opportunity" - Pharmaceutical Business Review
•	"Vioxx Whistle-blower Weighs in on Demoted Antibiotic Ketek" - USA Today